#Canada #Toronto #Perimeter Medical #Breast Surgeons #ASBrS IRC

Perimeter Medical Imaging AI Joins ASBrS Industry Relations Council

On September 8, 2025, Perimeter Medical Imaging AI, Inc. (stock symbols TSXV: PINK and OTCQX: PYNKF), a trailblazer in medical technology, announced its new membership in the Industry Relations Council (IRC) of the American Society of Breast Surgeons (ASBrS). This strategic move positions Perimeter to forge significant connections with key influencers in the field of breast surgery.

The American Society of Breast Surgeons stands as a prominent leadership organization for general surgeons dedicated to the care of patients suffering from breast diseases. Their commitment focuses on enhancing the standards of breast surgery and advocating for the surgeons who endeavor to provide exceptional patient care. The IRC is an assembly of companies engaged in diagnosing, treating, and providing comprehensive care for breast disease, aimed at fostering productive collaborations with surgical leaders.

Dr. Michael Berry, President of ASBrS, expressed enthusiasm regarding Perimeter’s involvement: "We welcome Perimeter as a member company of our IRC at a pivotal time for the field. While there have been many exciting advancements in breast care over the past few years, it’s evident that initiatives supporting optimal and cost-effective patient care are a priority for collaboration between industry and our organization."

Adrian Mendes, the CEO of Perimeter, reflected on the significance of this membership, stating, "We are honored to join other established and emerging companies within the ASBrS IRC. Our goal is to solidify our commercial presence with our current S-Series OCT system, while actively collaborating with the U.S. Food and Drug Administration (FDA) regarding the review of our investigational B-Series OCT product, which incorporates advanced AI capabilities."

Founded in Toronto, Canada, and with operations in Dallas, Texas, Perimeter Medical Imaging AI is committed to revolutionizing cancer surgery through ultra-high-resolution, real-time imaging technology. Their FDA-cleared Perimeter S-Series OCT system allows for cellular-level visualization of excised tissues, aiding in better surgical outcomes. Looking ahead, the Perimeter B-Series OCT with ImgAssist AI is currently under review following successful clinical trials and has garnered financial backing from the Cancer Prevention and Research Institute of Texas, with up to $7.4 million in grants.

As Perimeter continues on this path, it is essential to note that while the B-Series OCT is designated for investigational purposes only under U.S. law, the S-Series OCT has received 510(k) clearance, highlighting its potential in breast tissue evaluation and cancer margin assessments.

This collaboration with ASBrS not only signifies Perimeter’s commitment to improving surgical practices but also reflects their dedication to addressing unmet medical needs in cancer treatment through innovative technology. They aim to enhance the study and practice of breast surgery as members of the IRC, contributing to a future where breast care is enhanced by modern medical technology.

In summary, Perimeter Medical Imaging AI has taken a significant step by joining the ASBrS Industry Relations Council, aligning its advanced imaging capabilities with the efforts to advance surgical practices in breast medicine. This partnership promises to benefit both clinicians and patients through improved outcomes and collaborative initiatives. For further information about Perimeter and their groundbreaking technologies, you can visit their official website at perimetermed.com.

Perimeter’s commitment to excellence is underscored by their proactive engagement in vital conversations around breast health and technology, marking a transformative era in surgical oncology.